脓毒血症相关新型生物标志物研究进展  

Evaluation of novel biological markers of sepsis

作　　者：王翔[1] 易省阳[1] 

机构地区：[1]海南省人民医院急诊科,海口570311

出　　处：《中华实用诊断与治疗杂志》2015年第8期736-738,共3页Journal of Chinese Practical Diagnosis and Therapy

摘　　要：目前对降钙素原、白细胞介素、精氨酸加压素原和C反应蛋白等有关脓毒血症诊断、评估抗生素治疗效果和预后的生物标志物的研究引起临床关注。理想的标志物应能及时准确预测病情严重程度,可区分细菌感染、病毒感染和非感染引起的全身炎症反应综合征,指导进一步治疗。本文对脓毒血症相关新型生物标志物的研究进展作一综述。More researches focus on the biological markers of sepsis such as procalcitonin, interleukin, arginine vasopressin and C-reactive protein which are correlated with the diagnosis, assessment and prognosis of sepsis as well as the usage of antibiotics. The physicians need ideal markers to predict the severity of the disease timely and accurately and to distinguish bacterial infected or viral infected systemic inflammatory response syndrome from nonqnfected one. This paper reviews the research progress of biochemical markers of sepsis

关 键 词：脓毒血症 脓毒性休克 生物标志物 

分 类 号：R459.7[医药卫生—急诊医学]